SMi Group reports: the 3rd Annual AI in Drug Discovery is set to return to London in March 2022 with a key focus on the opportunities of machine learning and AI in drug development SMi Group is delighted to announce thesource https://www.openpr.com/news/2460884/exploring-the-impact-of-machine-learning-and-artificial